Ming‐Ming Zhou
Impact in
- Molecular Biology top 0.1%
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
- RNA modifications and cancer
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 60
- Ubiquitin and proteasome pathways 31
- Epigenetics and DNA Methylation 29
- Genomics and Chromatin Dynamics 28
- Cancer-related gene regulation 25
- Histone Deacetylase Inhibitors Research 24
- Protein Kinase Regulation and GTPase Signaling 16
- Oncology 25
- Co-authors
- Lei Zeng (55 shared papers)Roberto Sánchez (8 shared papers)Amjad Farooq (15 shared papers)Martin J. Walsh (15 shared papers)Jay A. Gingrich (8 shared papers)Shiraz Mujtaba (16 shared papers)Kyoko L. Yap (9 shared papers)Alena Lira (5 shared papers)
- Journals
- Journal of Biological Chemistry (12 papers)Structure (8 papers)Proceedings of the National Academy of Sciences (8 papers)Molecular Cell (7 papers)Journal of Medicinal Chemistry (6 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Ming‐Ming Zhou
203 papers receiving 19.0k citations
Ming‐Ming Zhou's Hit Papers
Peers
Comparison fields: 5 of 182
- Molecular Biology 14.2k
- Hematology 1.9k
- Virology 699
- Biological Psychiatry 347
- Cancer Research 1.8k
Countries citing papers authored by Ming‐Ming Zhou
This map shows the geographic impact of Ming‐Ming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ming Zhou more than expected).
Fields of papers citing papers by Ming‐Ming Zhou
This network shows the impact of papers produced by Ming‐Ming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ming Zhou. The network helps show where Ming‐Ming Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Ming Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure and ligand of a histone acetyltransferase bromodomain Hit paper breakdown → | 1999 | 1400 |
| 2 | Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a Hit paper breakdown → | 2010 | 1184 |
| 3 | Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior Hit paper breakdown → | 2007 | 711 |
| 4 | Identification of a serotonin/glutamate receptor complex implicated in psychosis Hit paper breakdown → | 2008 | 680 |
| 5 | Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice Hit paper breakdown → | 2004 | 678 |
| 6 | Bromodomain: an acetyl‐lysine binding domain Hit paper breakdown → | 2002 | 600 |
| 7 | Reading protein modifications with interaction domains Hit paper breakdown → | 2006 | 554 |
| 8 | 2008 | 494 | |
| 9 | 2014 | 399 | |
| 10 | 2004 | 395 | |
| 11 | 2003 | 381 | |
| 12 | 2011 | 361 | |
| 13 | 2006 | 357 | |
| 14 | 2003 | 323 | |
| 15 | 1995 | 320 | |
| 16 | Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions Hit paper breakdown → | 2020 | 290 |
| 17 | 2009 | 286 | |
| 18 | 2004 | 267 | |
| 19 | 2010 | 249 | |
| 20 | 2003 | 248 |
About Ming‐Ming Zhou
Ming‐Ming Zhou is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Virology and Hematology, having authored 207 papers that have together received 19.3k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (60 papers), Ubiquitin and proteasome pathways (31 papers), Epigenetics and DNA Methylation (29 papers), Genomics and Chromatin Dynamics (28 papers), Cancer-related gene regulation (25 papers), Histone Deacetylase Inhibitors Research (24 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and HIV Research and Treatment (16 papers). The work is most often cited by research in Molecular Biology (14.2k citations), Hematology (1.9k citations), Virology (699 citations), Biological Psychiatry (347 citations) and Cancer Research (1.8k citations). Ming‐Ming Zhou has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Lei Zeng, Roberto Sánchez, Amjad Farooq, Martin J. Walsh, Jay A. Gingrich, Shiraz Mujtaba, Kyoko L. Yap, Alena Lira, Christophe Dhalluin and Aneel K. Aggarwal. Their work appears in journals such as Journal of Biological Chemistry, Structure, Proceedings of the National Academy of Sciences, Molecular Cell and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.